Search

everythinglearnresearchcommunity

for

Search:↓

A high fat lard diet may protect against skin fibrosis and affect hair growth.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

People with Lichen sclerosus are more likely to have skin conditions like vitiligo and alopecia areata, heart disease risks, and other health issues. They should be checked for these, but screening plans shouldn't differ based on gender due to lack of data.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Lichen sclerosus et atrophicus is generally not considered precancerous, but there are exceptions.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Chaga mushrooms contain compounds that may promote hair growth better than common treatments.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

EPDS and MS might share an immune-related cause.